| Primary |
| Hypertension |
15.2% |
| Hepatic Neoplasm Malignant |
11.0% |
| Drug Use For Unknown Indication |
10.8% |
| Non-small Cell Lung Cancer |
9.9% |
| Pain |
7.7% |
| Metastatic Renal Cell Carcinoma |
5.7% |
| Prophylaxis |
5.4% |
| Renal Cell Carcinoma Stage Unspecified |
4.8% |
| Nausea |
3.5% |
| Diabetes Mellitus |
3.5% |
| Constipation |
3.3% |
| Renal Cell Carcinoma |
3.2% |
| Diarrhoea |
3.0% |
| Metastatic Malignant Melanoma |
2.7% |
| Insomnia |
2.1% |
| Abdominal Pain |
2.0% |
| Prophylaxis Of Nausea And Vomiting |
1.7% |
| Anaemia |
1.6% |
| Depression |
1.5% |
| Ascites |
1.4% |
|
| Vomiting |
15.5% |
| Pulmonary Embolism |
9.6% |
| Thrombocytopenia |
8.3% |
| Renal Failure |
7.8% |
| Rash |
6.1% |
| General Physical Health Deterioration |
5.6% |
| Weight Decreased |
4.9% |
| Pneumonia |
4.7% |
| Pyrexia |
4.4% |
| Sepsis |
4.1% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.6% |
| Renal Failure Acute |
3.3% |
| Respiratory Failure |
3.3% |
| Hepatic Encephalopathy |
3.2% |
| Pleural Effusion |
3.1% |
| Syncope |
2.9% |
| Deep Vein Thrombosis |
2.6% |
| Diarrhoea |
2.4% |
| Fatigue |
2.3% |
| Dyspnoea |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
12.7% |
| Hepatic Neoplasm Malignant |
12.1% |
| Drug Use For Unknown Indication |
12.0% |
| Hypertension |
11.0% |
| Non-small Cell Lung Cancer |
5.9% |
| Diarrhoea |
5.1% |
| Pain |
5.0% |
| Prophylaxis |
4.3% |
| Nausea |
4.3% |
| Diabetes Mellitus |
3.8% |
| Ascites |
3.3% |
| Insomnia |
2.8% |
| Chronic Obstructive Pulmonary Disease |
2.7% |
| Acute Myeloid Leukaemia |
2.3% |
| Muscle Spasms |
2.2% |
| Renal Cell Carcinoma |
2.2% |
| Rash |
2.2% |
| Renal Cell Carcinoma Stage Unspecified |
2.1% |
| Enteritis |
2.0% |
| Metastatic Renal Cell Carcinoma |
2.0% |
|
| Vomiting |
11.7% |
| Pulmonary Embolism |
9.0% |
| Thrombocytopenia |
8.6% |
| Oedema Peripheral |
6.6% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
6.3% |
| Renal Failure |
6.3% |
| Pyrexia |
6.0% |
| Weight Decreased |
5.3% |
| Deep Vein Thrombosis |
4.8% |
| Tetany |
4.4% |
| Off Label Use |
4.0% |
| Anaemia |
3.6% |
| Muscle Spasms |
3.2% |
| Myocardial Infarction |
3.1% |
| Toxicity To Various Agents |
3.1% |
| Hypocalcaemia |
2.9% |
| Pleural Effusion |
2.9% |
| Dyspnoea |
2.8% |
| Diarrhoea |
2.7% |
| Hepatic Encephalopathy |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.1% |
| Metastatic Renal Cell Carcinoma |
13.0% |
| Hepatic Neoplasm Malignant |
8.3% |
| Acute Myeloid Leukaemia |
7.2% |
| Pain |
6.0% |
| Hypertension |
5.6% |
| Renal Cell Carcinoma |
5.4% |
| Metastases To Bone |
5.0% |
| Renal Cancer |
4.3% |
| Nausea |
3.3% |
| Drug Use For Unknown Indication |
2.9% |
| Vomiting |
2.9% |
| Neoplasm Malignant |
2.3% |
| Prophylaxis Against Graft Versus Host Disease |
2.3% |
| Renal Cell Carcinoma Stage Unspecified |
2.3% |
| Acral Lentiginous Melanoma Stage Unspecified |
1.9% |
| Convulsion |
1.7% |
| Cough |
1.7% |
| Liver Transplant |
1.7% |
| Renal Cancer Metastatic |
1.4% |
|
| Wound Dehiscence |
12.7% |
| Weight Decreased |
7.8% |
| Osteonecrosis Of Jaw |
6.9% |
| Anaemia |
5.9% |
| Drug Ineffective |
5.9% |
| Renal Cell Carcinoma |
5.9% |
| Vomiting |
5.9% |
| Death |
4.9% |
| Troponin Increased |
4.9% |
| Weight Increased |
4.9% |
| White Blood Cell Count Decreased |
4.9% |
| Cystoid Macular Oedema |
3.9% |
| Pruritus |
3.9% |
| Syncope |
3.9% |
| Haemoglobin Abnormal |
2.9% |
| Hepatic Neoplasm Malignant |
2.9% |
| Infusion Related Reaction |
2.9% |
| Large Intestine Perforation |
2.9% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.9% |
| Pleural Effusion |
2.9% |
|
| Interacting |
| Hepatic Neoplasm Malignant |
28.0% |
| Anticoagulant Therapy |
16.0% |
| Acute Myocardial Infarction |
14.0% |
| Drug Use For Unknown Indication |
10.0% |
| Hiv Infection |
10.0% |
| Hypertension |
6.0% |
| Atrial Fibrillation |
4.0% |
| Hepatocellular Carcinoma |
4.0% |
| Metastatic Malignant Melanoma |
4.0% |
| Acute Myeloid Leukaemia |
2.0% |
| Prophylaxis |
2.0% |
|
| International Normalised Ratio Increased |
25.0% |
| Drug Interaction |
16.7% |
| Gastrointestinal Angiodysplasia |
12.5% |
| Asthenia |
8.3% |
| Myalgia |
8.3% |
| Stomatitis |
8.3% |
| Abdominal Pain |
4.2% |
| Chemotherapeutic Drug Level Increased |
4.2% |
| Gastrointestinal Haemorrhage |
4.2% |
| Squamous Cell Carcinoma |
4.2% |
| Treatment Noncompliance |
4.2% |
|
